Abstract
Purpose
The physicochemical characteristics of hyaluronic acid (HA) fillers can affect the outcome of minimally invasive aesthetic treatments. The effect of a novel HA-based filler manufactured with a novel 3D structure (XTRTM technology) was assessed in the nasolabial fold.
Patients and Methods
We performed a retrospective study of patients who underwent treatment of the nasolabial fold with a novel HA filler in our clinic. Treatment outcome was assessed at 3 and 6 months with wrinkle score, GAIS, and VAS.
Results
Eighteen patients were injected with the novel HA filler in the nasolabial fold. At six months, mean wrinkle scores were improved on both sides compared to baseline. GAIS and VAS were high at three and six months.
Conclusion
The HA-based filler manufactured with XTRTM technology is safe and effective in treating the nasolabial fold. Good aesthetic results were seen for up to 6 months. Patient satisfaction was high during the entire follow-up.
Ethical Approval
The study was conducted according to the Declaration of Helsinki. The authors confirm that ethical approval from the local institutional review board is not required as the data presented refers to standard routine clinical practice without deviating from the instructions for use of the CE-marked medical device. All patients signed an informed consent form. Patients in and gave written permission for image publication.
Acknowledgments
Editorial assistance was provided by ERA ms S.r.l. and funded by Relife S.r.l.
Disclosure
V.W. discloses personal fees (key opinion leader/speaker) from Relife. A. H. I. A. has nothing to disclose for this work.